Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.

ABSTRACT:

SUBMITTER: Jain P 

PROVIDER: S-EPMC5904008 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature